<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00798018</url>
  </required_header>
  <id_info>
    <org_study_id>ICLT</org_study_id>
    <nct_id>NCT00798018</nct_id>
  </id_info>
  <brief_title>Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena</brief_title>
  <official_title>Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sichuan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sichuan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been proven that tracheal tube inflated with lidocaine could decrease the
      post-intubation sore throat in nitrous oxide anesthesia. In the study, the investigators
      would like to evaluate the effect of lidocaine inflation in non-nitrous oxide anesthesia and
      compare the effect of tetracaine, the best mucosal local anesthetics with lidocaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The female patients receiving gynecological surgeries were divided into air, saline and 2%
      lidocaine and 1% tetracaine groups of 25 each using sealed envelope technique. The cuff of
      the endotracheal tube was inflated by the inflation medium (with the help of intracuff
      pressure monitoring device) to occlude the leak around the tube by the Minimal Occlusive
      Volume Technique. This was done by the same anaesthesiologist in all the patients. The cuff
      volume and pressure were then recorded. The primary outcome of the study was to evaluate the
      post-intubation sore throat using the visual analogue scale 6h, 24h and 48h after extubation.
      The secondary outcomes were incidence of complications during emergence of anesthesia and
      after extubation. Intra-cuff pressure monitoring was done with a pressure monitor, which
      consisted of the pressure gauge, three-way stopcock whose one end was attached to the
      pressure monitoring line. Net volume of the inflation medium was noted. Volume of the
      inflation medium, intra cuff pressure, duration from intubation to extubation and volume of
      the inflation medium withdrawn from the cuff was noted. Incidence (Yes/No) of tube
      intolerance, coughing on tube, restlessness, hoarseness, sore throat, breathlessness and
      laryngospasm were analyzed by the anaesthesiologist who did not know which group the patient
      belonged to.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale(0-100mm) by the Subject.</measure>
    <time_frame>6 hours, 12 hours, 24 hours, 48 hours after extubation</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pharyngitis</condition>
  <arm_group>
    <arm_group_label>Air</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>air was used to inflate the cuff.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline was used to inflate the cuff.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2% lidocaine was used to inflate the cuff.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tetracaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1% tetracaine was used to inflate the cuff.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% lidocaine</intervention_name>
    <description>lidocaine: 2%, injected into the cuff to seal the space between the trachea and the tube at minimal volume</description>
    <arm_group_label>lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Air injected into the cuff to seal the space between the trachea and the tube at minimal volume</description>
    <arm_group_label>Air</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1% tetracaine</intervention_name>
    <description>tetracaine: 1%, injected into the cuff to seal the space between the trachea and the tube at minimal volume</description>
    <arm_group_label>tetracaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N.S</intervention_name>
    <description>0.9% Normal saline injected into the cuff to seal the space between the trachea and the tube at minimal volume</description>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of the age group 18-60 years

          -  patients belonging to ASA grade I and II undergoing gynecological surgeries in supine
             position under general anesthesia with controlled ventilation using Poly Vinyl
             Chloride ETT (same type and make in all patients)

        Exclusion Criteria:

          -  anticipated difficult intubation

          -  more than one attempt for intubation

          -  need for naso gastric tube

          -  episode of coughing and straining

          -  history of respiratory tract infection and smoking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han Huang, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Aensthesiology, West China 2nd Hospital, Sichuan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, West China Second Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Estebe JP, Delahaye S, Le Corre P, Dollo G, Le Naoures A, Chevanne F, Ecoffey C. Alkalinization of intra-cuff lidocaine and use of gel lubrication protect against tracheal tube-induced emergence phenomena. Br J Anaesth. 2004 Mar;92(3):361-6.</citation>
    <PMID>14970135</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2008</study_first_submitted>
  <study_first_submitted_qc>November 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2008</study_first_posted>
  <results_first_submitted>June 1, 2009</results_first_submitted>
  <results_first_submitted_qc>December 17, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 18, 2009</results_first_posted>
  <last_update_submitted>December 17, 2009</last_update_submitted>
  <last_update_submitted_qc>December 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr.</name_title>
    <organization>Department of Anesthesiology, West China Second Hospital</organization>
  </responsible_party>
  <keyword>lidocaine</keyword>
  <keyword>tetracaine</keyword>
  <keyword>tracheal intubation</keyword>
  <keyword>pharyngitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study started in November 2008 and finished in February 2009, in total 100 patients were enrolled and all of them finished this study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Air Alone</title>
          <description>Only air was injected into the cuff, as the routine practice</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline</title>
          <description>normal saline was used to inflate the cuff</description>
        </group>
        <group group_id="P3">
          <title>Lidocaine</title>
          <description>2% lidiocaine was used to inflate the cuff</description>
        </group>
        <group group_id="P4">
          <title>Tetracaine</title>
          <description>1% tetracaine was used to inflate the cuff</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Air Alone</title>
          <description>Only air was injected into the cuff, as the routine practice</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline</title>
          <description>normal saline was used to inflate the cuff</description>
        </group>
        <group group_id="B3">
          <title>Lidocaine</title>
          <description>2% lidiocaine was used to inflate the cuff</description>
        </group>
        <group group_id="B4">
          <title>Tetracaine</title>
          <description>1% tetracaine was used to inflate the cuff</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39" spread="8"/>
                    <measurement group_id="B2" value="44" spread="9"/>
                    <measurement group_id="B3" value="42" spread="7"/>
                    <measurement group_id="B4" value="41" spread="10"/>
                    <measurement group_id="B5" value="42" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analogue Scale(0-100mm) by the Subject.</title>
        <description>visual analogue scale (VAS) was used to evaluate the post-intubation sore throat. The VAS was a well-recongnized standard tool for rating of pain. The VAS measures exactly 100 mm. 0 means no pain and 100 means the worst pain that one can image. Patient marks a point on the line that matches the amount of pain he or she feels.</description>
        <time_frame>6 hours, 12 hours, 24 hours, 48 hours after extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Air Alone</title>
            <description>Only air was injected into the cuff, as the routine practice</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>normal saline was used to inflate the cuff</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine</title>
            <description>2% lidiocaine was used to inflate the cuff</description>
          </group>
          <group group_id="O4">
            <title>Tetracaine</title>
            <description>1% tetracaine was used to inflate the cuff</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analogue Scale(0-100mm) by the Subject.</title>
          <description>visual analogue scale (VAS) was used to evaluate the post-intubation sore throat. The VAS was a well-recongnized standard tool for rating of pain. The VAS measures exactly 100 mm. 0 means no pain and 100 means the worst pain that one can image. Patient marks a point on the line that matches the amount of pain he or she feels.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" spread="37"/>
                    <measurement group_id="O2" value="40" spread="31"/>
                    <measurement group_id="O3" value="22" spread="17"/>
                    <measurement group_id="O4" value="9" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" spread="33"/>
                    <measurement group_id="O2" value="38" spread="19"/>
                    <measurement group_id="O3" value="25" spread="15"/>
                    <measurement group_id="O4" value="13" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43" spread="39"/>
                    <measurement group_id="O2" value="41" spread="30"/>
                    <measurement group_id="O3" value="20" spread="18"/>
                    <measurement group_id="O4" value="7" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>48h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" spread="36"/>
                    <measurement group_id="O2" value="43" spread="25"/>
                    <measurement group_id="O3" value="23" spread="19"/>
                    <measurement group_id="O4" value="9" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Air Alone</title>
          <description>Only air was injected into the cuff, as the routine practice</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline</title>
          <description>normal saline was used to inflate the cuff</description>
        </group>
        <group group_id="E3">
          <title>Lidocaine</title>
          <description>2% lidiocaine was used to inflate the cuff</description>
        </group>
        <group group_id="E4">
          <title>Tetracaine</title>
          <description>1% tetracaine was used to inflate the cuff</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Han Huang</name_or_title>
      <organization>Department of Anesthesiology, West China Second Hospital</organization>
      <phone>80-028-8550-3753</phone>
      <email>huanghan1981@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

